Media Thread, page-15765

A friend of mine, after I told him about Imugene some months ago, later told me he sold all his other shares and bought shares in Imugene.

I told him earlier that it was a high risk, high reward option - it all depended on the results of clinical trials. The share price could go to zero if all the clinical trials failed or showed significant side effects. Or the share price could go to many dollars per share if they had the cure for cancer or even the cure for some cancers.

I told my friend he needed to put his eggs in more than one basket but that advice fell on deaf ears.

Everyone has their own outlook on their investments, I guess.

Good luck to all long holders.